Market News

Independent Franchise Partners Llp Has Boosted Its Abbott Labs (ABT) Stake by $10.34 Million; Gagnon Advisors Has Lowered Its Lumber Liquidators Holdings (LL) Stake by $3.35 Million as Share Price Rose

Independent Franchise Partners Llp increased its stake in Abbott Labs (ABT) by 1.99% based on its latest 2017Q3 regulatory filing with the SEC. Independent Franchise Partners Llp bought 195,187 shares as the company’s stock declined 3.42% while stock markets rallied. The institutional investor held 10.02M shares of the major pharmaceuticals company at the end of 2017Q3, valued at $534.84 million, up from 9.83 million at the end of the previous reported quarter. Independent Franchise Partners Llp who had been investing in Abbott Labs for a number of months, seems to be bullish on the $103.49 billion market cap company. The stock increased 0.46% or $0.27 during the last trading session, reaching $59.26. About 1.77 million shares traded. Abbott Laboratories (NYSE:ABT) has risen 15.90% since February 23, 2017 and is uptrending. It has underperformed by 0.80% the S&P500.

Gagnon Advisors Llc decreased its stake in Lumber Liquidators Holdings Inc (LL) by 33.98% based on its latest 2017Q3 regulatory filing with the SEC. Gagnon Advisors Llc sold 88,287 shares as the company’s stock rose 89.65% with the market. The hedge fund held 171,518 shares of the consumer services company at the end of 2017Q3, valued at $6.69M, down from 259,805 at the end of the previous reported quarter. Gagnon Advisors Llc who had been investing in Lumber Liquidators Holdings Inc for a number of months, seems to be less bullish one the $695.32M market cap company. The stock increased 2.39% or $0.57 during the last trading session, reaching $24.41. About 374,514 shares traded. Lumber Liquidators Holdings, Inc. (NYSE:LL) has risen 154.19% since February 23, 2017 and is uptrending. It has outperformed by 137.49% the S&P500.

Analysts await Lumber Liquidators Holdings, Inc. (NYSE:LL) to report earnings on February, 27 before the open. They expect $0.09 EPS, up 145.00% or $0.29 from last year’s $-0.2 per share. LL’s profit will be $2.56 million for 67.81 P/E if the $0.09 EPS becomes a reality. After $0.07 actual EPS reported by Lumber Liquidators Holdings, Inc. for the previous quarter, Wall Street now forecasts 28.57% EPS growth.

Among 12 analysts covering Lumber Liquidators Holdings (NYSE:LL), 4 have Buy rating, 1 Sell and 7 Hold. Therefore 33% are positive. Lumber Liquidators Holdings had 28 analyst reports since August 6, 2015 according to SRatingsIntel. The rating was upgraded by Oppenheimer on Friday, May 19 to “Outperform”. The firm has “Buy” rating by Wedbush given on Wednesday, October 25. Jefferies maintained the shares of LL in report on Thursday, September 28 with “Hold” rating. Stephens downgraded Lumber Liquidators Holdings, Inc. (NYSE:LL) rating on Thursday, August 6. Stephens has “Equal Weight” rating and $13 target. The rating was downgraded by Goldman Sachs on Thursday, December 17 to “Sell”. As per Monday, October 2, the company rating was maintained by Morgan Stanley. On Tuesday, October 31 the stock rating was maintained by Piper Jaffray with “Hold”. The stock of Lumber Liquidators Holdings, Inc. (NYSE:LL) has “Hold” rating given on Tuesday, October 31 by Stifel Nicolaus. The firm has “Buy” rating by Oppenheimer given on Tuesday, August 1. The stock of Lumber Liquidators Holdings, Inc. (NYSE:LL) earned “Hold” rating by Jefferies on Tuesday, October 31.

Investors sentiment decreased to 1.27 in Q3 2017. Its down 0.56, from 1.83 in 2017Q2. It fall, as 24 investors sold LL shares while 40 reduced holdings. 34 funds opened positions while 47 raised stakes. 22.21 million shares or 4.11% more from 21.33 million shares in 2017Q2 were reported. Moreover, Aperio Ltd Liability has 0% invested in Lumber Liquidators Holdings, Inc. (NYSE:LL) for 8,082 shares. First Mercantile Trust reported 14,036 shares. Royal Fincl Bank Of Canada reported 3,256 shares. Rbf Llc stated it has 0.96% in Lumber Liquidators Holdings, Inc. (NYSE:LL). Renaissance Lc has 437,800 shares. Ameriprise Fin Inc invested in 0% or 204,938 shares. Next Fincl Gru, a Texas-based fund reported 1,665 shares. Comerica National Bank & Trust stated it has 30,041 shares or 0.01% of all its holdings. Price T Rowe Assocs Md invested in 0.02% or 2.84 million shares. Texas Permanent School Fund reported 20,743 shares or 0.01% of all its holdings. Disciplined Growth Investors Mn holds 248,566 shares or 0.2% of its portfolio. Blair William & Co Il owns 8,650 shares. Citadel Advisors Limited Liability Com holds 0% of its portfolio in Lumber Liquidators Holdings, Inc. (NYSE:LL) for 67,814 shares. Louisiana State Employees Retirement Systems stated it has 11,500 shares. 587 were reported by Pnc Finance Services.

Independent Franchise Partners Llp, which manages about $13.30 billion and $11.16B US Long portfolio, decreased its stake in S&P Global Inc by 1.22M shares to 3.77 million shares, valued at $589.22M in 2017Q3, according to the filing.

Among 25 analysts covering Abbott Laboratories (NYSE:ABT), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. Abbott Laboratories had 105 analyst reports since July 24, 2015 according to SRatingsIntel. The company was maintained on Thursday, October 19 by Citigroup. The rating was downgraded by Northland Capital on Thursday, September 28 to “Hold”. Goldman Sachs downgraded it to “Neutral” rating and $90 target in Friday, November 13 report. On Thursday, August 31 the stock rating was maintained by BMO Capital Markets with “Hold”. The rating was maintained by Barclays Capital on Thursday, January 25 with “Overweight”. As per Friday, February 5, the company rating was upgraded by Argus Research. The stock of Abbott Laboratories (NYSE:ABT) has “Buy” rating given on Saturday, August 29 by BTIG Research. As per Tuesday, January 30, the company rating was maintained by Citigroup. The firm has “Buy” rating given on Tuesday, October 10 by Jefferies. Citigroup initiated the shares of ABT in report on Thursday, August 17 with “Hold” rating.

Investors sentiment decreased to 0.87 in Q3 2017. Its down 0.01, from 0.88 in 2017Q2. It fall, as 47 investors sold ABT shares while 563 reduced holdings. 111 funds opened positions while 421 raised stakes. 1.21 billion shares or 0.79% less from 1.22 billion shares in 2017Q2 were reported. Symphony Asset Mgmt Lc owns 89,339 shares. Livforsakringsbolaget Skandia Omsesidigt invested in 60,617 shares or 0.29% of the stock. Ghp accumulated 20,648 shares. Cs Mckee LP has invested 1.71% in Abbott Laboratories (NYSE:ABT). Brandywine Tru Communication reported 161,230 shares. Moors And Cabot Inc stated it has 64,178 shares. Btim Corporation reported 0.04% stake. Cohen Lawrence B owns 3,905 shares. Jacobus Wealth Mngmt holds 0.83% in Abbott Laboratories (NYSE:ABT) or 59,521 shares. One Association holds 0.11% of its portfolio in Abbott Laboratories (NYSE:ABT) for 30,629 shares. Cypress Gru holds 0.9% of its portfolio in Abbott Laboratories (NYSE:ABT) for 79,036 shares. Thomas White Interest Ltd accumulated 22,894 shares. Private Wealth Inc stated it has 9,826 shares or 0.22% of all its holdings. Nomura Holding Inc reported 267,153 shares or 0.03% of all its holdings. Macnealy Hoover stated it has 0.97% in Abbott Laboratories (NYSE:ABT).

Since September 22, 2017, it had 0 buys, and 10 sales for $35.12 million activity. 52,700 shares were sold by Contreras Jaime, worth $2.74 million. Salvadori Daniel Gesua Sive had sold 62,460 shares worth $3.31M on Tuesday, September 26. Shares for $27,213 were sold by PEDERSON MICHAEL J on Friday, February 16. On Friday, February 16 Watkin Jared sold $17,609 worth of Abbott Laboratories (NYSE:ABT) or 297 shares. Fussell Stephen R sold $3.36 million worth of Abbott Laboratories (NYSE:ABT) on Friday, February 16. 42,665 shares were sold by Ford Robert B, worth $2.69M on Tuesday, January 30.

Leave a Reply

Your email address will not be published. Required fields are marked *